Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07834424 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Direct Pulp Capping With Biodentine in Permanent Teeth With Reversible Pulpitis

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed
    • Primary completion date changed from estimate of Sep 2026 to Sep 25, 2026
    • Study completion date changed from estimate of Sep 2026 to Sep 30, 2026
  2. Re-verified, no change to tracked fields
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluates the clinical and radiographic outcomes of direct pulp capping using Biodentine (Septodont, Saint-Maur-des-Fossés, France), a calcium silicate-based cement, in mature permanent teeth diagnosed with reversible pulpitis following carious or mechanical pulp exposure. Biodentine was placed as a full-thickness (bulk) capping and interim restoration, with a definitive composite restoration completed at a later visit. Pulp vitality, postoperative pain, and radiographic healing are assessed over a 6-month follow-up period.
Trial Details
NCT Number NCT07834424
Lead Sponsor University of Medicine and Pharmacy at Ho Chi Minh City
Conditions
(from sponsor)		 Reversible Pulpitis, Dental Pulp Exposure
Related terms Dental Pulp Exposure
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov